Determination of serum tumor necrosis factor-alpha (TNF-α) levels in metabolic syndrome patients from Saudi population

Abstract

Objectives: To detect the relationship between serum tumor necrosis factor-alpha (TNF-α) and metabolic syndrome (MetS) components in patients of the Saudi population.
 Methods: This cross-sectional study was carried out at Jouf University Saudi Arabia from September 2019 to August 2020 and comprised of 183 individuals (91 cases and 92 controls). The blood samples were drawn from the patients visiting two tertiary care settings of Al Jouf province. Biochemical analysis was conducted on various instruments, and serum TNF-α was measured by the ELISA method.
 Results: The levels of serum glucose fasting, lipid profile, HbA1c and body mass index (BMI) were raised significantly in cases of MetS than controls (p = 0.001). Serum TNF-α was significantly higher in patients (58.04 ± 15.44) than controls (48.81 ± 10.30). It was correlated with the BMI, blood HbA1c, serum fasting glucose (SFG) and serum high density lipoprotein (HDL). The weak positive correlation was found with BMI (r = 0.18; p = 0.01), serum glucose (r = 0.21; p = 0.007) and HbA1c (r = 0.14; p = 0.04), but found negative association with serum HDL (r = -0.18; p = 0.01).
 Conclusion: The serum TNF-α was raised in metabolic syndrome patients than the healthy controls. It was positively associated with high BMI, serum fasting glucose, and HbA1c and found linked and negatively linked to low HDL levels in MetS patients in the Saudi population.
 doi: https://doi.org/10.12669/pjms.37.3.3897
 How to cite this:Ullah MI, Alzahrani B, Alsrhani A, Atif M, Alameen AAM, Ejaz H. Determination of serum tumor necrosis factor-alpha (TNF-α) levels in metabolic syndrome patients from Saudi population. Pak J Med Sci. 2021;37(3):---------. doi: https://doi.org/10.12669/pjms.37.3.3897
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Inflammatory Markers and Atherogenic Coefficient: Early Markers of Metabolic Syndrome

“…Inflammatory markers, such as E-selectin, vascular cell adhesion molecule 1, and CRP, were also indicated to be related to insulin resistance and MetSyn in a study on elderly patients by Ingelsson et al (19). Additionally, Ullah et al reported significantly higher serum levels of TNF-α in participants with MetSyn than in healthy controls (24). Moreover, low-grade inflammation, as indicated through elevated serum inflammatory markers, including CRP and IL-6, is linked to peripheral arterial disease severity and coronary artery disease, as shown by Jacobs et al (20).…”

“…The sample size of the present study was calculated using a study by Ullah et al (24) and the below formula. Assuming the same number of samples in both groups and with a significance level of α = 0.05 and a power of 1-β = 0.99, the minimum sample size of each study arm was estimated at 74 subjects.…”

Biological Role of Zinc in Liver Cirrhosis: An Updated Review

“…Various factors are responsible for developing Zn deficiency or can progress to alter the Zn metabolism in liver cirrhosis ( Table 1 ). These factors include insufficient intake alterations in amino acid and protein metabolism, lessened portosystemic shunts, hepatic extraction, impaired absorption due to alcohol influence, and the effects of endotoxins and cytokines, primarily IL-6 [ 63 , 64 ].…”

Obesity, Diabetes Mellitus, and Vascular Impediment as Consequences of Excess Processed Food Consumption

“…Over the last 25 years, multiple studies reported that fatty tissue hyperplasia and hypertrophy frequently correlated with the negative impact of adipose tissue metabolic equilibrium [100,101]. Additionally, various studies said that tumor necrosis factor-alpha (TNF-α) was significantly raised among obese individuals, eventually rooted in IR, and surfaced the notion of an inflammatory element of obesity [86,[102][103][104][105]. This inflammatory pathological issue is known as "meta-inflammation," a clinical disease of chronic, low-grade inflammation noticed among obese patients [106,107].…”